Merry Alan, Seddon Mary
School of Population Health Group, University of Auckland, New Zealand.
N Z Med J. 2006 Jul 21;119(1238):U2086.
The evidence is incontrovertible--we are inadvertently harming an unacceptable number of our patients by the very healthcare intended to help them. Most developed countries have responded to this evidence with substantial funding for dedicated patient-safety campaigns. New Zealand has a reasonable legislative foundation in relation to this problem but to date has not galvanised action at either the national or the organisational level. The reasons for this inaction are explored in this article and include a lack of understanding of the causes of medical error and of the difference between error and violation. Insistence on randomised controlled trial evidence and a business model is to misunderstand the constructs at stake and may inhibit the implementation of urgently needed safety strategies that are clearly sensible and worthwhile.
证据确凿——我们原本旨在帮助患者的医疗保健却在不经意间伤害了数量多得令人无法接受的患者。大多数发达国家已针对这一证据投入大量资金开展专门的患者安全运动。新西兰在这个问题上有合理的立法基础,但迄今为止,无论是在国家层面还是组织层面,都未能推动相关行动。本文探讨了这种不作为的原因,包括对医疗差错的成因以及差错与违规行为之间差异的理解不足。坚持要有随机对照试验证据和商业模式,是对相关关键概念的误解,可能会阻碍实施显然合理且值得的迫切需要的安全策略。